跳至主要内容
临床试验/NL-OMON52467
NL-OMON52467招募中不适用

Gut microbiome dynamics in metastasized or irresectable colorectal cancer: initiating a prospective multicenter cohort - GIMICC

niversitair Medisch Centrum Groningen0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age >= 18 years
  • - Patients with histologically confirmed CRC with an indication for
  • neo-adjuvant or palliative systemic anti-tumor therapy (ANY combination of
  • chemotherapy with/without anti-VEGF of anti-EGFR therapy, or immunotherapy)
  • - Measurable disease according to RECIST v1.1.
  • - Stored pathological specimens available
  • - Life expectancy >= 12 weeks
  • - Signed Informed Consent Form
  • - Ability to comply with protocol

排除标准

  • - Previous (neo)adjuvant chemotherapy < 6 months
  • - Previous radiotherapy on the small or large intestine < 1 month
  • - Previous surgery of the small or large intestine < 1 month
  • - Uncontrolled inflammatory bowel disease
  • - Participation in a study with a potential effect on the gut microbiome

研究者

相似试验